| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Aeglea BioTherapeutics, Inc. | Chief Operating Officer | Employee Stock Option (right to buy) | 130,000 | 23 Aug 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| SYRE | Aeglea BioTherapeutics, Inc. | 23 Aug 2022 | 1 | $0 | 4 | Chief Operating Officer | 25 Aug 2022, 19:36 |
| SYRE | Aeglea BioTherapeutics, Inc. | 17 Feb 2022 | 1 | $0 | 4 | Chief Operating Officer | 22 Feb 2022, 15:54 |